Home Newsfeeds Sofbank’s Arm Ltd Said Late Thursday, It Would Pursue U.S. IPO

Sofbank’s Arm Ltd Said Late Thursday, It Would Pursue U.S. IPO

-Reuters https://www.reuters.com/markets/deals/softbanks-arm-pursue-us-only-listing-this-year-2023-03-03/

byCharles Gross

March 3, 2023

1 minute read

-Reuters

https://www.reuters.com/markets/deals/softbanks-arm-pursue-us-only-listing-this-year-2023-03-03/

UBS Maintains Buy on Biogen, Raises Price Target to $309

By Benzinga Newsdesk

October 6, 8:59 AM

UBS analyst Colin Bristow maintains Biogen (NASDAQ:BIIB) with a Buy and raises the price target from $238 to $309.

BIIB

News

ReposiTrak Attains SOC Type 2 Audit Recertification; Successful Completion Underscores Continuing Commitment To Providing Data-Secure Solutions

By Benzinga Newsdesk

January 24, 11:06 AM

Successful completion underscores continuing commitment to providing data-secure solutions ReposiTrak, the largest network of food supply chain operators connected through one supply chain, food safety and supplier

PCYG

Ford Recalls 456,565 SUVs And Trucks Over Low Battery Issue, NHTSA Warns Of Safety Risks: Report

By Nabaparna Bhattacharya

April 17, 11:40 AM

Ford recalls 456,565 SUVs and trucks in the U.S. due to low battery issue, NHTSA flags safety concerns; Toyota also conducts recall for Prius door handle faults.

Reported Late Thursday, Autolus Announces Pricing Of $150M Public Offering Of 75M American Depositary Shares, Representing 75M Ordinary Shares At A Price Of $2/ADS

By Benzinga Newsdesk

December 9, 2:51 AM

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of its previously announced underwritten public

AUTL

Sofbank’s Arm Ltd Said Late Thursday, It Would Pursue U.S. IPO

Related Posts

UBS Maintains Buy on Biogen, Raises Price Target to $309

ReposiTrak Attains SOC Type 2 Audit Recertification; Successful Completion Underscores Continuing Commitment To Providing Data-Secure Solutions

Ford Recalls 456,565 SUVs And Trucks Over Low Battery Issue, NHTSA Warns Of Safety Risks: Report

Reported Late Thursday, Autolus Announces Pricing Of $150M Public Offering Of 75M American Depositary Shares, Representing 75M Ordinary Shares At A Price Of $2/ADS